Inicio/Acciones/TFX

TFX

USD

Teleflex Incorporated Common Stock

$121.990+1.270 (1.052%)

Precio en Tiempo Real

Healthcare

Medical Instruments & Supplies

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$120.720

Máximo

$122.350

Mínimo

$121.200

Volumen

0.50M

Fundamentos de la Empresa

Capitalización de Mercado

5.4B

Industria

Medical Instruments & Supplies

País

United States

Estadísticas de Negociación

Volumen Promedio

0.92M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $118.7Actual $121.990Máximo $249.91

Noticias Relacionadas

12 jun 2025 · 10:29

GlobeNewswire

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients

WAYNE, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced findings from a new multinational study reporting efficacy of

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients

11 jun 2025 · 10:30

GlobeNewswire

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month

Timed with National Men's Health Month, the Prostate Monster ad campaign shines a light on quality-of-life issues associated with benign prostatic hyperplasia or BPH—a condition affecting millions of men1—and encourages